Atea Pharmaceuticals, Inc.
Nasdaq · CIK 0001593899 · Fiscal year end 1231
Latest reported period: Latest published period
Recent financials
| Metric | Current | Prior | Change |
|---|
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 4 | Atea Pharmaceuticals, Inc. | 2026-06-23 | 0001193125-26-279728 |
| 4 | Atea Pharmaceuticals, Inc. | 2026-06-23 | 0001193125-26-279726 |
| 4 | Atea Pharmaceuticals, Inc. | 2026-06-23 | 0001193125-26-279721 |
| 4 | Atea Pharmaceuticals, Inc. | 2026-06-23 | 0001193125-26-279719 |
| 4 | Atea Pharmaceuticals, Inc. | 2026-06-23 | 0001193125-26-279718 |
| 4 | Atea Pharmaceuticals, Inc. | 2026-06-23 | 0001193125-26-279720 |
| 4 | Atea Pharmaceuticals, Inc. | 2026-05-20 | 0001193125-26-232612 |
| 10-Q | Atea Pharmaceuticals, Inc. | 2026-05-12 | 0001193125-26-219678 |
| 4 | Atea Pharmaceuticals, Inc. | 2026-03-13 | 0001193125-26-106547 |
| 10-K | Atea Pharmaceuticals, Inc. | 2026-03-05 | 0001193125-26-094159 |
| 4 | Atea Pharmaceuticals, Inc. | 2026-02-03 | 0001193125-26-036270 |
| 4 | Atea Pharmaceuticals, Inc. | 2026-02-03 | 0001193125-26-036269 |
| 4 | Atea Pharmaceuticals, Inc. | 2026-02-03 | 0001193125-26-036268 |
| 4 | Atea Pharmaceuticals, Inc. | 2026-02-03 | 0001193125-26-036261 |
| 4 | Atea Pharmaceuticals, Inc. | 2026-02-03 | 0001193125-26-036281 |
| 4 | Atea Pharmaceuticals, Inc. | 2026-02-03 | 0001193125-26-036272 |
| 10-Q | Atea Pharmaceuticals, Inc. | 2025-11-12 | 0001193125-25-277815 |
| 10-Q | Atea Pharmaceuticals, Inc. | 2025-08-07 | 0000950170-25-105123 |